Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logo

RICHTER Richter Gedeon Vegyeszeti Gyar Nyrt Share Price

0.000.00%
hu flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Momentum

Relative Strength (%)
1m-6.6%
3m-2.95%
6m+12.62%
1yr+0.05%
Volume Change (%)
10d/3m+36.92%
Price vs... (%)
52w High-4.87%
50d MA+6.31%
200d MA+12.57%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)7.9
PEG Ratio (f)n/a
EPS Growth (f)-2.54%
Dividend Yield (f)4.64%
Valuation (ttm)IndustryMarket
Price to Book Value1.44
Price to Tang. Book1.88
Price to Free Cashflow15.15
Price to Sales2.09
EV to EBITDA6.2

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.1%
Return on Equity24.75%
Operating Margin25.88%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueHUFm444,356445,484507,794566,776630,595766,323.64801,493.7210.1%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-32.8+2.23+20.59+101.22+36.69+44.51-5.25n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Richter Gedeon Vegyeszeti Gyar Nyrt EPS forecast chart

Profile Summary

Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
October 2nd, 1923
Public Since
November 9th, 1994
No. of Employees
12,180
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hu flag iconBudapest Stock Exchange
Shares in Issue
185,821,070

RICHTER Share Price Performance

Upcoming Events for RICHTER

Q4 2022 Richter Gedeon Vegyeszeti Gyar Nyrt Earnings Release

Richter Gedeon Vegyeszeti Gyar Nyrt Annual Shareholders Meeting

Q1 2023 Richter Gedeon Vegyeszeti Gyar Nyrt Earnings Release

Similar to RICHTER

FAQ

Or unlock with your email

Or unlock with your email